Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G White

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Clinical Pharmacology and Therapeutics|December 1, 1975
The efficacy of carbamazepine combinations in epilepsyJ J Cereghino, J T Brock, J C Van Meter, et al.
Electroencephalography and Clinical Neurophysiology|December 1, 1980
Electroencephalographic changes during whole body hyperthermia in humansM Dubois, S Sato, D E Lees, et al.
Federation Proceedings|July 1, 1985
Advances in the clinical development of antiepileptic drugsR J Porter, B J Hessie, J J Cereghino, et al.
Cleveland Clinic Quarterly|January 1, 1984
Antiepileptic Drug Development ProgramR J Porter, J J Cereghino, G D Gladding, et al.
Journal of Cardiac Failure|September 25, 1999
Effect of inotrope withdrawal on morbidity and mortality in patients with chronic heart failure: results of the vesnarinone trial withdrawal substudy. Vest Withdrawal Substudy GroupO Soran, J D Young, R Holubkov, et al.
Epilepsia|December 1, 1975
A multiple-dose study of mexiletine (Kö 1173)J J Cereghino, J T Brock, J C Van Meter, et al.
Neurology|June 1, 1975
Ethosuximide in the treatment of absence (peptit mal) seizuresT R Browne, F E Dreifuss, P R Dyken, et al.
Epilepsia|December 1, 1975
A single-dose study of mexiletine (Kö 1173)J J Cereghino, B J Wilder, H J Kupferberg, et al.
Epilepsia|November 1, 1985
Efficacy of nafimidone in the treatment of intractable partial seizures: report of a two-center pilot studyD M Treiman, A J Wilensky, E Ben-Menachem, et al.
The New England Journal of Medicine|December 17, 1998
A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial InvestigatorsJ N Cohn, S O Goldstein, B H Greenberg, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Clinical Pharmacology and Therapeutics|December 1, 1975
The efficacy of carbamazepine combinations in epilepsyJ J Cereghino, J T Brock, J C Van Meter, et al.
Electroencephalography and Clinical Neurophysiology|December 1, 1980
Electroencephalographic changes during whole body hyperthermia in humansM Dubois, S Sato, D E Lees, et al.
Federation Proceedings|July 1, 1985
Advances in the clinical development of antiepileptic drugsR J Porter, B J Hessie, J J Cereghino, et al.
Cleveland Clinic Quarterly|January 1, 1984
Antiepileptic Drug Development ProgramR J Porter, J J Cereghino, G D Gladding, et al.
Journal of Cardiac Failure|September 25, 1999
Effect of inotrope withdrawal on morbidity and mortality in patients with chronic heart failure: results of the vesnarinone trial withdrawal substudy. Vest Withdrawal Substudy GroupO Soran, J D Young, R Holubkov, et al.
Epilepsia|December 1, 1975
A multiple-dose study of mexiletine (Kö 1173)J J Cereghino, J T Brock, J C Van Meter, et al.
Neurology|June 1, 1975
Ethosuximide in the treatment of absence (peptit mal) seizuresT R Browne, F E Dreifuss, P R Dyken, et al.
Epilepsia|December 1, 1975
A single-dose study of mexiletine (Kö 1173)J J Cereghino, B J Wilder, H J Kupferberg, et al.
Epilepsia|November 1, 1985
Efficacy of nafimidone in the treatment of intractable partial seizures: report of a two-center pilot studyD M Treiman, A J Wilensky, E Ben-Menachem, et al.
The New England Journal of Medicine|December 17, 1998
A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial InvestigatorsJ N Cohn, S O Goldstein, B H Greenberg, et al.
Pageof 3